NEUROCRINE BIOSCIENCES INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for NEUROCRINE BIOSCIENCES INC (NBIX), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are NBIX insiders buying or selling?
NEUROCRINE BIOSCIENCES INC insiders reported 0 open-market buys ($0) and 365 sells ($520.4M) across 365 Form 4 filings — a net selling position of $520.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 13, 2026)
Insider sentiment
Net sellingNet insider flow of $520.4M in net selling.
Recent NBIX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | Ingrid Delaet | Chief Regulatory Officer | Sale | 4.4K | $181.02 | $790.5K |
| Jul 13, 2026 | Darin Lippoldt | Chief Legal Officer | Sale | 10.0K | $179.60 | $1.8M |
| Jul 9, 2026 | Ingrid Delaet | Chief Regulatory Officer | Sale | 14.6K | $178.65 | $2.6M |
| Jun 30, 2026 | Darin Lippoldt | Chief Legal Officer | Sale | 10.0K | $170.15 | $1.7M |
| Jun 9, 2026 | SHERWIN STEPHEN A | Director | Sale | 25.0K | $165.32 | $4.1M |
| Jun 8, 2026 | Leslie V Norwalk | Director | Sale | 1.3K | $168.06 | $210.1K |
| Jun 4, 2026 | Julie Cooke | Chief Human Resources Officer | Sale | 36.9K | $156.22 | $5.8M |
| Jun 2, 2026 | Jude Onyia | Chief Scientific Officer | Sale | 11.0K | $160.25 | $1.8M |
| Jun 2, 2026 | Ingrid Delaet | Chief Regulatory Officer | Sale | 2.3K | $156.71 | $354.3K |
| May 29, 2026 | Jude Onyia | Chief Scientific Officer | Sale | 11.0K | $155.53 | $1.7M |
| May 28, 2026 | David W. Boyer | Chief Corp. Affairs Officer | Sale | 3.9K | $156.64 | $609.0K |
| May 21, 2026 | Kevin Charles Gorman | Director | Sale | 245.1K | $154.33 | $37.8M |
| May 18, 2026 | POPS RICHARD F | Director | Sale | 15.0K | $157.65 | $2.4M |
| May 14, 2026 | Leslie V Norwalk | Director | Sale | 3.8K | $155.01 | $590.6K |
| Jan 20, 2026 | Kyle Gano | Chief Executive Officer | Sale | 36.4K | $132.70 | $4.8M |
| Dec 17, 2025 | Leslie V Norwalk | Director | Sale | 6.2K | $152.78 | $945.7K |
| Dec 10, 2025 | Darin Lippoldt | Chief Legal Officer | Sale | 4.4K | $159.65 | $698.6K |
| Dec 4, 2025 | LYONS GARY A | Director | Sale | 15.0K | $152.61 | $2.3M |
| Dec 2, 2025 | Eric Benevich | Chief Commercial Officer | Sale | 6.0K | $151.74 | $905.9K |
| Nov 26, 2025 | MORROW GEORGE J | Director | Sale | 15.0K | $143.37 | $2.2M |
| Nov 6, 2025 | William H Rastetter | Director | Sale | 18.0K | $151.82 | $2.7M |
| Nov 5, 2025 | Kyle Gano | Chief Executive Officer | Sale | 300 | $141.97 | $42.6K |
| Aug 11, 2025 | Kevin Charles Gorman | Director | Sale | 106.3K | $126.41 | $13.4M |
| Jul 11, 2025 | Ingrid Delaet | Chief Regulatory Officer | Sale | 457 | $135.00 | $61.7K |
| Jul 11, 2025 | Jude Onyia | Chief Scientific Officer | Sale | 59.8K | $130.46 | $7.8M |
Showing the 25 most recent of 365 Form 4 filings for NEUROCRINE BIOSCIENCES INC.
Most active NBIX insiders
- Darin Lippoldt39 filings
- Eric Benevich33 filings
- Julie Cooke31 filings
- Kevin Charles Gorman26 filings
- Eiry Roberts25 filings
Ask anything about NBIX insider activity
Use Trabud's AI agent to query NEUROCRINE BIOSCIENCES INC's Form 4 history in plain English — "Show me NBIX CEO purchases this year" or compare it against any other ticker.
Open the AI agentNBIX insider trading FAQ
Are NEUROCRINE BIOSCIENCES INC insiders buying or selling?
Across 365 SEC Form 4 filings, NEUROCRINE BIOSCIENCES INC (NBIX) insiders reported 0 open-market purchases totaling $0 and 365 sales totaling $520.4M. That is a net selling position of $520.4M.
How many insiders trade NBIX stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for NEUROCRINE BIOSCIENCES INC. The most recent filing was accepted on Jul 13, 2026.
Where does Trabud get NBIX insider trading data?
All NBIX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.